Search Ontology:
ChEBI

D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-beta-D-Glcp

Term ID
CHEBI:147059
Synonyms
  • (3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
  • D-gluco-hexopyranosyl-(1->4)-alpha-D-gluco-hexopyranosyl-(1->4)-beta-D-gluco-hexopyranose
  • D-glucopyranosyl-(1->4)-alpha-D-glucopyranosyl-(1->4)-beta-D-glucopyranose
  • Glc(?1-4)Glc(a1-4)b-Glc
Definition
A glucotriose consisting of D-glucopyranose, α-D-glucopyranose and β-D-glucopyranose residues joined in sequence by two (1→4) glycosidic bonds. The configuration of the anomeric centre at the non-reducing terminus is not specified.
References
  • glygen:G06851NM
  • glytoucan:G06851NM
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-beta-D-Glcp
Phenotype where environments contain D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-beta-D-Glcp
Phenotype modified by environments containing D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-beta-D-Glcp
Phenotype affecting D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-beta-D-Glcp
Human Disease Model